I had seen that, but I am not sure if those are Dr. Sacha's talk or the talks of people from his lab where he is just listed as lab directors typical are. I don't recall any of them mentioning PRO 140 or leronlimab.

I believe this is the one you are referencing...

296 CMV VACCINE VECTOR-INDUCED PROTECTION AGAINST SIV IN
MAURITIAN CYNOMOLGUS MACAQUES
Justin Greene, Daniel Malouli, Nicholas Maier, Abigail Ventura, Roxanne
Gilbride, Whitney Weber, Helen Wu, Junwei Gao, Michael K. Axthelm,
Jeremy Smedley, Jeffrey D. Lifson, Klaus Fruh, Louis J. Picker, Scott Hansen,
Jonah Sacha